These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 29781033)
1. Microarray analysis of circular RNA expression profiles associated with gemcitabine resistance in pancreatic cancer cells. Xu C; Yu Y; Ding F Oncol Rep; 2018 Jul; 40(1):395-404. PubMed ID: 29781033 [TBL] [Abstract][Full Text] [Related]
2. Identifying microRNA-mRNA regulatory network in gemcitabine-resistant cells derived from human pancreatic cancer cells. Shen Y; Pan Y; Xu L; Chen L; Liu L; Chen H; Chen Z; Meng Z Tumour Biol; 2015 Jun; 36(6):4525-34. PubMed ID: 25722110 [TBL] [Abstract][Full Text] [Related]
3. Resistance to gemcitabine is mediated by the circ_0036627/miR-145/S100A16 axis in pancreatic cancer. Yu S; Wang M; Zhang H; Guo X; Qin R J Cell Mol Med; 2024 Jun; 28(12):e18444. PubMed ID: 38924205 [TBL] [Abstract][Full Text] [Related]
4. Circ_0092367 Inhibits EMT and Gemcitabine Resistance in Pancreatic Cancer via Regulating the miR-1206/ESRP1 Axis. Yu S; Wang M; Zhang H; Guo X; Qin R Genes (Basel); 2021 Oct; 12(11):. PubMed ID: 34828307 [TBL] [Abstract][Full Text] [Related]
5. Genomic analysis of drug resistant pancreatic cancer cell line by combining long non-coding RNA and mRNA expression profling. Zhou M; Ye Z; Gu Y; Tian B; Wu B; Li J Int J Clin Exp Pathol; 2015; 8(1):38-52. PubMed ID: 25755691 [TBL] [Abstract][Full Text] [Related]
6. [Establish a gemcitabine-resistant pancreatic cancer cell line SW1990/GZ and research the relationship between SW1990/GZ and pancreatic cancer stem cell]. An Y; Yao J; Wei JS; Lu ZP; Cai HH; Dai CC; Qian ZY; Xu ZK; Miao Y Zhonghua Wai Ke Za Zhi; 2010 Jul; 48(13):999-1003. PubMed ID: 21054984 [TBL] [Abstract][Full Text] [Related]
7. Identification of lncRNAs and Their Functional Network Associated with Chemoresistance in SW1990/GZ Pancreatic Cancer Cells by RNA Sequencing. Li D; Qian X; Xu P; Wang X; Li Z; Qian J; Yao J DNA Cell Biol; 2018 Oct; 37(10):839-849. PubMed ID: 30113217 [TBL] [Abstract][Full Text] [Related]
8. Identification of chemoresistance-related mRNAs based on gemcitabine-resistant pancreatic cancer cell lines. Zhou J; Zhang L; Zheng H; Ge W; Huang Y; Yan Y; Zhou X; Zhu W; Kong Y; Ding Y; Wang W Cancer Med; 2020 Feb; 9(3):1115-1130. PubMed ID: 31823522 [TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of microRNA-messenger RNA regulatory network in gemcitabine-resistant bladder cancer cells. Zhang S; Chang YY; Gong YW; Gao YJ; Guo Q; Wang YH; Zhao YL; Wang ZP J Cell Biochem; 2019 Apr; 120(4):6347-6360. PubMed ID: 30304549 [TBL] [Abstract][Full Text] [Related]
10. Emodin reverses gemcitabine resistance in pancreatic cancer cells via the mitochondrial apoptosis pathway in vitro. Liu DL; Bu H; Li H; Chen H; Guo HC; Wang ZH; Tong HF; Ni ZL; Liu HB; Lin SZ Int J Oncol; 2012 Apr; 40(4):1049-57. PubMed ID: 22159556 [TBL] [Abstract][Full Text] [Related]
11. PARP14 promotes the proliferation and gemcitabine chemoresistance of pancreatic cancer cells through activation of NF-κB pathway. Yao N; Chen Q; Shi W; Tang L; Fu Y Mol Carcinog; 2019 Jul; 58(7):1291-1302. PubMed ID: 30968979 [TBL] [Abstract][Full Text] [Related]
12. circFARP1 enables cancer-associated fibroblasts to promote gemcitabine resistance in pancreatic cancer via the LIF/STAT3 axis. Hu C; Xia R; Zhang X; Li T; Ye Y; Li G; He R; Li Z; Lin Q; Zheng S; Chen R Mol Cancer; 2022 Jan; 21(1):24. PubMed ID: 35045883 [TBL] [Abstract][Full Text] [Related]
13. Mechanism Comparison of Gemcitabine and Dasatinib-Resistant Pancreatic Cancer by Integrating mRNA and miRNA Expression Profiles. Chen Z; Zhao L; Shi K; Chen B Clin Lab; 2018 May; 64(5):749-757. PubMed ID: 29739052 [TBL] [Abstract][Full Text] [Related]
14. MiR-760 enhances sensitivity of pancreatic cancer cells to gemcitabine through modulating Integrin β1. Yang D; Hu Z; Xu J; Tang Y; Wang Y; Cai Q; Zhu Z Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31693728 [TBL] [Abstract][Full Text] [Related]
15. [The mechanism of resistance to 2', 2'-difluorodeoxycytidine (gemcitabine) in a pancreatic cancer cell line]. Yao J; Feng FY; Lin C; Zhang XY; Fu M; Liang X; Yang Y Zhonghua Zhong Liu Za Zhi; 2005 Dec; 27(12):721-6. PubMed ID: 16483481 [TBL] [Abstract][Full Text] [Related]
16. Profiling and bioinformatics analyses reveal differential circular RNA expression in radioresistant esophageal cancer cells. Su H; Lin F; Deng X; Shen L; Fang Y; Fei Z; Zhao L; Zhang X; Pan H; Xie D; Jin X; Xie C J Transl Med; 2016 Jul; 14(1):225. PubMed ID: 27465405 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA Profiling Implies New Markers of Gemcitabine Chemoresistance in Mutant p53 Pancreatic Ductal Adenocarcinoma. Dhayat SA; Mardin WA; Seggewiß J; Ströse AJ; Matuszcak C; Hummel R; Senninger N; Mees ST; Haier J PLoS One; 2015; 10(11):e0143755. PubMed ID: 26606261 [TBL] [Abstract][Full Text] [Related]
18. Circular RNA Expression Profile of Pancreatic Ductal Adenocarcinoma Revealed by Microarray. Li H; Hao X; Wang H; Liu Z; He Y; Pu M; Zhang H; Yu H; Duan J; Qu S Cell Physiol Biochem; 2016; 40(6):1334-1344. PubMed ID: 27997903 [TBL] [Abstract][Full Text] [Related]
19. Hsa-miR-3178/RhoB/PI3K/Akt, a novel signaling pathway regulates ABC transporters to reverse gemcitabine resistance in pancreatic cancer. Gu J; Huang W; Wang X; Zhang J; Tao T; Zheng Y; Liu S; Yang J; Chen ZS; Cai CY; Li J; Wang H; Fan Y Mol Cancer; 2022 May; 21(1):112. PubMed ID: 35538494 [TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of circular RNA expression profiles in cisplatin-resistant non-small cell lung cancer cell lines. Song L; Cui Z; Guo X Acta Biochim Biophys Sin (Shanghai); 2020 Sep; 52(9):944-953. PubMed ID: 32716023 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]